Peptide microarray-based identification of dormancy-associated Mycobacterium tuberculosis antigens inducing immune responses among latent tuberculosis infection individuals in Thailand

[1]  C. Leepiyasakulchai,et al.  Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738 , 2022, PloS one.

[2]  E. Salina,et al.  Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review) , 2021, International journal of molecular sciences.

[3]  H. Yanai,et al.  Circulating IgA/IgG memory B cell against Mycobacterium tuberculosis dormancy-associated antigens Rv2659c and Rv3128c in active and latent tuberculosis. , 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  Thomas W Cho,et al.  A review of the BCG vaccine and other approaches toward tuberculosis eradication , 2021, Human vaccines & immunotherapeutics.

[5]  B. Yousefi,et al.  Overview of multistage subunit tuberculosis vaccines: advantages and challenges , 2020 .

[6]  E. Ellsworth,et al.  Inhibiting Mycobacterium tuberculosis DosRST Signaling by Targeting Response Regulator DNA Binding and Sensor Kinase Heme , 2019, ACS chemical biology.

[7]  M. Tameris,et al.  Dose Optimization of H56:IC31 Vaccine for Tuberculosis‐Endemic Populations. A Double‐Blind, Placebo‐controlled, Dose‐Selection Trial , 2019, American journal of respiratory and critical care medicine.

[8]  R. Walker,et al.  The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial , 2018, npj Vaccines.

[9]  T. Ottenhoff,et al.  IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals , 2018, PloS one.

[10]  T. Ottenhoff,et al.  Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression. , 2017, Tuberculosis.

[11]  N. Ahmed,et al.  Mycobacterium tuberculosis DosR Regulon Gene Rv2004c Encodes a Novel Antigen with Pro-inflammatory Functions and Potential Diagnostic Application for Detection of Latent Tuberculosis , 2017, Front. Immunol..

[12]  S. Kaufmann,et al.  Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers , 2017, Expert review of vaccines.

[13]  Y. Zhang,et al.  Subunit Vaccines Consisting of Antigens from Dormant and Replicating Bacteria Show Promising Therapeutic Effect against Mycobacterium Bovis BCG Latent Infection , 2017, Scandinavian journal of immunology.

[14]  N. Ahmed,et al.  Mycobacterial Dormancy Systems and Host Responses in Tuberculosis , 2017, Front. Immunol..

[15]  T. Ottenhoff,et al.  Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of Mycobacterium tuberculosis in Individuals with Latent Tuberculosis Infection , 2017, Journal of immunology research.

[16]  A. Raja,et al.  Dynamic IgG antibody response to immunodominant antigens of M. tuberculosis for active TB diagnosis in high endemic settings. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[17]  K. Fink,et al.  Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool , 2016, EBioMedicine.

[18]  T. Ottenhoff,et al.  Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia , 2016, Clinical and Vaccine Immunology.

[19]  Xueqiong Wu,et al.  Immune responses to latent tuberculosis antigen Rv2659c in Chinese populations. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[20]  K. Tokunaga,et al.  Genetic Diversity and Dynamic Distribution of Mycobacterium tuberculosis Isolates Causing Pulmonary and Extrapulmonary Tuberculosis in Thailand , 2014, Journal of Clinical Microbiology.

[21]  K. Chida,et al.  Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  Surendra K Sharma,et al.  Relevance of latent TB infection in areas of high TB prevalence. , 2012, Chest.

[23]  S. Kaufmann,et al.  Mycobacterium tuberculosis: success through dormancy. , 2012, FEMS microbiology reviews.

[24]  S. Kaufmann,et al.  Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting , 2012, BMC Infectious Diseases.

[25]  D. Sherman,et al.  The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. , 2012, The Journal of clinical investigation.

[26]  G. Schoolnik,et al.  A multistage tuberculosis vaccine that confers efficient protection before and after exposure , 2011, Nature Medicine.

[27]  T. Scriba,et al.  Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease. , 2010, Vaccine.

[28]  T. Ottenhoff,et al.  Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection , 2010, European journal of immunology.

[29]  T. Ottenhoff,et al.  Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection , 2009, European Respiratory Journal.

[30]  S Miltenyi,et al.  Correlation analysis between frequencies of circulating antigen‐specific IgG‐bearing memory B cells and serum titers of antigen‐specific IgG , 1999, European journal of immunology.

[31]  Aneeya K. Samantara,et al.  Advantages and Challenges , 2020 .